Skip to main content
Log in

Treatment of chronic congenital lactic acidosis by oral administration of dichloroacetate

  • Published:
Journal of Inherited Metabolic Disease

Abstract

Sodium dichloroacetate (DCA) was administered orally at a dose of 50 mg per kg body weight twice or three times per day to a newborn infant with lactic acidosis of unknown cause (patient 1) and to a 15-year-old boy with mitochondrial encephalomyopathy associated with lactic acidosis (patient 2). In patient 1, during treatment with DCA, DCA accumulated in the blood judging from the findings that the urinary excretion of DCA increased cumulatively and the blood lactate level rapidly decreased to the normal range. In patient 2, the blood DCA level gradually increased during treatment to a concentration of 250 µgml−1 and the blood lactate level decreased and was maintained within the normal range. DCA was detected in the brain (25 µg g tissue−1) and the liver, kidney and muscle (33.8, 33.8 and 26.3 µg g tissue−1, respectively) obtained at autopsy of patient 1, and in the cerebrospinal fluid of patient 2 at a concentration of 125 µg ml−1 when the blood concentration was 250 µg ml−1. The lactate levels in the cerebrospinal fluid decreased from 7 and 4mmoll−1 to 2.4 and 2.6 mmoll−1 in patients 1 and 2, respectively. Thus DCA may be useful in clinical treatment of chronic congenital lactic acidosis because it seems to cross the blood-brain barrier. However, it must be given at non-toxic doses, determined by monitoring the concentrations of lactate and DCA in the blood, because orally administered DCA tends to accumulate in tissues.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Abemayor, E., Kovachich, G. B. and Haugaard, N. Effects of dichloroacetate on brain pyruvate dehydrogenase.J. Neurochem. 42 (1984) 38–42

    Google Scholar 

  • Aynsley-Green, A., Weindling, A. M., Soltesz, G., Ross, B. and Jenkins, P. A. Dichloroacetate in the treatment of congenital lactic acidosis.J. Inher. Metab. Dis. 7 (1984) 26

    Google Scholar 

  • Blass, J. P. Inborn errors of pyruvate metabolism. In: Stanbury, J. B., Wyngaarden, J. B., Fredrickson, D. A., Goldstein, J. L. and Brown, M. S. (Eds.)The Metabolic Basis of Inherited Disease. McGraw-Hill, New York, 1983, pp. 193–203

    Google Scholar 

  • Coude, F. X., Saudubray, J. M., Demaugre, F., Marsac, C. and Leroux, J. P. Dichloroacetate as treatment for congenital lactic acidosis.N. Engl. J. Med. 229 (1978) 1365–1366

    Google Scholar 

  • Crabb, D. W., Yount, E. A. and Harris, P. A. The metabolic effects of dichloroacetate.Metabolism 30 (1981) 1024–1039

    Google Scholar 

  • Demaugre, F., Cepanec, C. and Leroux, J. P. Characterization of oxalate as a catabolite of dichloroacetate responsible for the inhibition of gluconeogenesis and pyruvate carboxylation in rat liver cells.Biochem. Biophys. Res. Commun. 85 (1978) 1180–1185

    Google Scholar 

  • Evans, O. B. Dichloroacetate tissue concentrations and its relationship to hypolactatemia and pyruvate dehydrogenase activation.Biochem. Pharmacol. 31 (1982) 3124–3126

    Google Scholar 

  • Evans, O. B. Effects of dichloroacetate on brain tissue pyruvate dehydrogenase.J. Neurochem. 41 (1983) 1052–1056

    Google Scholar 

  • Evans, O. B. and Stacpoole, P. W. Brief treatment with dichloroacetate does not modify suspected subacute necrotizing encephalomyelitis.Ann. Neurol. 8 (1980) 647–648

    Google Scholar 

  • Evans, O. B. and Stacpoole, P. W. Prolonged hypolactatemia and increased total pyruvate dehydrogenase activity by dichloroacetate.Biochem. Pharmacol. 31 (1982) 1295–1300

    Google Scholar 

  • Gutman, I. and Wahlgeld, A.l-(+)-Lactate: determination with lactate dehydrogenase and NAD. In: Bergmeyer, H. U. (ed.)Methods of Enzymatic Analysis. Academic Press, New York, 1974, pp. 1464–1468

    Google Scholar 

  • Haworth, J. C., Robinson, B. H. and Perry, T. L. Lactic acidosis due to pyruvate carboxylase deficiency.J. Inher. Metab. Dis. 4 (1981) 57–58

    Google Scholar 

  • Katz, R., Tai, C. N. and Diener, R. M. Dichloroacetate sodium: 3-month oral toxicity studies in rats and dogs.Toxicol. Appl. Pharmacol. 57 (1981) 273–287

    Google Scholar 

  • Kuroda, Y., Toshima, K., Watanabe, T., Kobashi, H., Ito, M., Takeda, E. and Miyao, M. Effects of dichloroacetate on pyruvate metabolism in rat brainin vivo.Pediatr. Res. 18 (1984) 936–938

    Google Scholar 

  • Lukas, G., Vyas, K. H., Brindly, S. D., Sher, A. R. L. and Wagner, W. E., Jr. Biological disposition of sodium dichloroacetate in animals and humans after intravenous administration.J. Pharm. Sci. 69 (1980) 419–421

    Google Scholar 

  • Maesaka, H., Komiya, K., Misugi, K. and Tada, K. Hyperalaninemia, hyperpyruvicemia and lactic acidosis due to pyruvate carboxylase deficiency of the liver: treatment with thiamine and lipoic acid.Eur. J. Pediatr. 122 (1976) 159–168

    Google Scholar 

  • McKhann, G., Francois, B. and Evrard, P. Long term use of low dichloroacetate in a child with congenital lactic acidosis.Pediatr. Res. 14 (1980) 167

    Google Scholar 

  • Robinson, B. H., Taylor, J., Francois, B., Beaudet, A. L. and Peterson, D. F. Lactic acidosis neurological deterioration and compromised cellular pyruvate oxidation due to a defect in the reoxidation of cytoplasmically generated NADH.Eur. J. Pediatr. 140 (1983) 98–101

    Google Scholar 

  • Stacpoole, P. W., Harman, E. M., Curry, S. H., Baumgartner, T. G. and Misbin, R. I. Treatment of lactic acidosis with dichloroacetate.N. Engl. J. Med. 309 (1983) 390–396

    Google Scholar 

  • Stacpoole, P. W., Moore, G. W. and Kornhauser, D. M. Toxicity of chronic dichloroacetate.N. Engl. J. Med. 300 (1979) 372

    Google Scholar 

  • Toshima, K., Kuroda, Y., Hashimoto, T., Ito, M., Watanabe, T., Miyao, M. and Ii, K. Enzymologic studies and therapy of Leigh's disease associated with pyruvate decarboxylase deficiency.Pediatr. Res. 16 (1982) 430–435

    Google Scholar 

  • Wells, P. G., Moore, G. W., Rabin, D., Wilkinson, G. R., Oates, J. A. and Stacpoole, P. W. Metabolic effects and pharmacokinetics of intravenously administered dichloroacetate in humans.Diabetologia 19 (1980) 109–113

    Google Scholar 

  • Whitehouse, S., Cooper, R. H and Randle, P. J. Mechanism of activation of pyruvate dehydrogenase by dichloroacetate and other halogenated carboxylic acids.Biochem. J. 141 (1974) 761–774

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kuroda, Y., Ito, M., Toshima, K. et al. Treatment of chronic congenital lactic acidosis by oral administration of dichloroacetate. J Inherit Metab Dis 9, 244–252 (1986). https://doi.org/10.1007/BF01799655

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01799655

Keywords

Navigation